nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Upper gastrointestinal haemorrhage—Entecavir—hepatitis B	0.0366	0.0888	CcSEcCtD
Pazopanib—Phosphorus low—Adefovir Dipivoxil—hepatitis B	0.0357	0.0867	CcSEcCtD
Pazopanib—ABCG2—Lamivudine—hepatitis B	0.0292	0.735	CbGbCtD
Pazopanib—Blood phosphorus decreased—Adefovir Dipivoxil—hepatitis B	0.0284	0.0689	CcSEcCtD
Pazopanib—Frequent bowel movements—Telbivudine—hepatitis B	0.0147	0.0357	CcSEcCtD
Pazopanib—Lipase increased—Telbivudine—hepatitis B	0.0118	0.0286	CcSEcCtD
Pazopanib—TAOK1—blood plasma—hepatitis B	0.0117	0.0536	CbGeAlD
Pazopanib—Abdominal pain lower—Telbivudine—hepatitis B	0.0109	0.0265	CcSEcCtD
Pazopanib—ABCB1—Lamivudine—hepatitis B	0.0105	0.265	CbGbCtD
Pazopanib—LYN—blood plasma—hepatitis B	0.00926	0.0425	CbGeAlD
Pazopanib—Localised oedema—Lamivudine—hepatitis B	0.00774	0.0188	CcSEcCtD
Pazopanib—Amylase increased—Telbivudine—hepatitis B	0.00729	0.0177	CcSEcCtD
Pazopanib—Platelet count decreased—Entecavir—hepatitis B	0.0071	0.0172	CcSEcCtD
Pazopanib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.00709	0.0172	CcSEcCtD
Pazopanib—MAP3K2—blood plasma—hepatitis B	0.00678	0.0311	CbGeAlD
Pazopanib—FGF1—blood plasma—hepatitis B	0.00638	0.0293	CbGeAlD
Pazopanib—FLT1—blood plasma—hepatitis B	0.00559	0.0256	CbGeAlD
Pazopanib—STK10—blood plasma—hepatitis B	0.00529	0.0243	CbGeAlD
Pazopanib—TAOK3—blood plasma—hepatitis B	0.00527	0.0242	CbGeAlD
Pazopanib—UGT1A1—blood plasma—hepatitis B	0.005	0.0229	CbGeAlD
Pazopanib—KDR—blood plasma—hepatitis B	0.00472	0.0217	CbGeAlD
Pazopanib—ITK—blood—hepatitis B	0.0047	0.0216	CbGeAlD
Pazopanib—CSF1R—blood plasma—hepatitis B	0.00461	0.0211	CbGeAlD
Pazopanib—MAP3K9—liver—hepatitis B	0.00446	0.0205	CbGeAlD
Pazopanib—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00433	0.0105	CcSEcCtD
Pazopanib—Rhinorrhoea—Telbivudine—hepatitis B	0.00428	0.0104	CcSEcCtD
Pazopanib—TAOK1—blood—hepatitis B	0.00428	0.0196	CbGeAlD
Pazopanib—KIT—blood plasma—hepatitis B	0.00419	0.0192	CbGeAlD
Pazopanib—SLCO1B1—blood plasma—hepatitis B	0.00416	0.0191	CbGeAlD
Pazopanib—Amylase increased—Lamivudine—hepatitis B	0.00411	0.00996	CcSEcCtD
Pazopanib—SH2B3—blood—hepatitis B	0.00403	0.0185	CbGeAlD
Pazopanib—PLK4—blood—hepatitis B	0.00363	0.0166	CbGeAlD
Pazopanib—Musculoskeletal pain—Telbivudine—hepatitis B	0.00351	0.00851	CcSEcCtD
Pazopanib—STK16—blood—hepatitis B	0.00343	0.0157	CbGeAlD
Pazopanib—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00342	0.0083	CcSEcCtD
Pazopanib—Hepatic failure—Entecavir—hepatitis B	0.00341	0.00827	CcSEcCtD
Pazopanib—LYN—blood—hepatitis B	0.00339	0.0156	CbGeAlD
Pazopanib—RIOK2—blood—hepatitis B	0.00337	0.0155	CbGeAlD
Pazopanib—TAOK1—liver—hepatitis B	0.00335	0.0154	CbGeAlD
Pazopanib—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00333	0.00807	CcSEcCtD
Pazopanib—SH2B3—liver—hepatitis B	0.00315	0.0145	CbGeAlD
Pazopanib—STK36—blood—hepatitis B	0.00303	0.0139	CbGeAlD
Pazopanib—PI4KB—blood—hepatitis B	0.00298	0.0137	CbGeAlD
Pazopanib—LIMK2—blood—hepatitis B	0.00293	0.0134	CbGeAlD
Pazopanib—Blood creatinine increased—Entecavir—hepatitis B	0.00287	0.00696	CcSEcCtD
Pazopanib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0028	0.00679	CcSEcCtD
Pazopanib—Abdominal pain upper—Entecavir—hepatitis B	0.0028	0.00679	CcSEcCtD
Pazopanib—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00276	0.0067	CcSEcCtD
Pazopanib—STK16—liver—hepatitis B	0.00268	0.0123	CbGeAlD
Pazopanib—LYN—liver—hepatitis B	0.00265	0.0122	CbGeAlD
Pazopanib—FGFR3—liver—hepatitis B	0.00264	0.0121	CbGeAlD
Pazopanib—RIOK2—liver—hepatitis B	0.00264	0.0121	CbGeAlD
Pazopanib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00264	0.0064	CcSEcCtD
Pazopanib—FLT4—blood—hepatitis B	0.00263	0.0121	CbGeAlD
Pazopanib—PIP4K2C—blood—hepatitis B	0.00262	0.012	CbGeAlD
Pazopanib—Pancreatitis—Entecavir—hepatitis B	0.0026	0.0063	CcSEcCtD
Pazopanib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00253	0.00615	CcSEcCtD
Pazopanib—MAP3K2—blood—hepatitis B	0.00248	0.0114	CbGeAlD
Pazopanib—Neutropenia—Entecavir—hepatitis B	0.00248	0.00601	CcSEcCtD
Pazopanib—Rhinorrhoea—Lamivudine—hepatitis B	0.00241	0.00585	CcSEcCtD
Pazopanib—Dysphonia—Lamivudine—hepatitis B	0.00238	0.00576	CcSEcCtD
Pazopanib—STK36—liver—hepatitis B	0.00237	0.0109	CbGeAlD
Pazopanib—CYP2C8—blood plasma—hepatitis B	0.00236	0.0108	CbGeAlD
Pazopanib—FGF1—blood—hepatitis B	0.00234	0.0107	CbGeAlD
Pazopanib—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00234	0.00567	CcSEcCtD
Pazopanib—PI4KB—liver—hepatitis B	0.00233	0.0107	CbGeAlD
Pazopanib—LCK—blood—hepatitis B	0.00232	0.0107	CbGeAlD
Pazopanib—Abdominal pain upper—Telbivudine—hepatitis B	0.0023	0.00558	CcSEcCtD
Pazopanib—LIMK2—liver—hepatitis B	0.00229	0.0105	CbGeAlD
Pazopanib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00227	0.0055	CcSEcCtD
Pazopanib—Haematuria—Entecavir—hepatitis B	0.00225	0.00546	CcSEcCtD
Pazopanib—Nasopharyngitis—Telbivudine—hepatitis B	0.00225	0.00546	CcSEcCtD
Pazopanib—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00225	0.00545	CcSEcCtD
Pazopanib—Hepatobiliary disease—Entecavir—hepatitis B	0.00223	0.00542	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00222	0.00539	CcSEcCtD
Pazopanib—CYP1A2—blood plasma—hepatitis B	0.00221	0.0101	CbGeAlD
Pazopanib—FGFR2—blood—hepatitis B	0.00221	0.0101	CbGeAlD
Pazopanib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0022	0.00533	CcSEcCtD
Pazopanib—Abdominal distension—Telbivudine—hepatitis B	0.00219	0.00531	CcSEcCtD
Pazopanib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00218	0.00529	CcSEcCtD
Pazopanib—Rectal haemorrhage—Lamivudine—hepatitis B	0.00216	0.00525	CcSEcCtD
Pazopanib—Oropharyngeal pain—Lamivudine—hepatitis B	0.00215	0.00521	CcSEcCtD
Pazopanib—Oedema peripheral—Entecavir—hepatitis B	0.00209	0.00507	CcSEcCtD
Pazopanib—FLT4—liver—hepatitis B	0.00206	0.00944	CbGeAlD
Pazopanib—PIP4K2C—liver—hepatitis B	0.00205	0.00939	CbGeAlD
Pazopanib—FLT1—blood—hepatitis B	0.00205	0.00939	CbGeAlD
Pazopanib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00204	0.00495	CcSEcCtD
Pazopanib—Neutropenia—Telbivudine—hepatitis B	0.00204	0.00493	CcSEcCtD
Pazopanib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00203	0.00493	CcSEcCtD
Pazopanib—FGFR1—liver—hepatitis B	0.00203	0.00932	CbGeAlD
Pazopanib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00203	0.00492	CcSEcCtD
Pazopanib—EPHB6—blood—hepatitis B	0.00202	0.00928	CbGeAlD
Pazopanib—Musculoskeletal pain—Lamivudine—hepatitis B	0.00198	0.0048	CcSEcCtD
Pazopanib—MAP3K2—liver—hepatitis B	0.00194	0.0089	CbGeAlD
Pazopanib—STK10—blood—hepatitis B	0.00194	0.00889	CbGeAlD
Pazopanib—TAOK3—blood—hepatitis B	0.00193	0.00885	CbGeAlD
Pazopanib—PDGFRA—blood—hepatitis B	0.00192	0.0088	CbGeAlD
Pazopanib—Alopecia—Entecavir—hepatitis B	0.00187	0.00454	CcSEcCtD
Pazopanib—Mental disorder—Entecavir—hepatitis B	0.00186	0.0045	CcSEcCtD
Pazopanib—Malnutrition—Entecavir—hepatitis B	0.00185	0.00448	CcSEcCtD
Pazopanib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00184	0.00445	CcSEcCtD
Pazopanib—UGT1A1—blood—hepatitis B	0.00183	0.00839	CbGeAlD
Pazopanib—FGF1—liver—hepatitis B	0.00183	0.00839	CbGeAlD
Pazopanib—LCK—liver—hepatitis B	0.00182	0.00834	CbGeAlD
Pazopanib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0018	0.00437	CcSEcCtD
Pazopanib—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00177	0.0043	CcSEcCtD
Pazopanib—Mouth ulceration—Lamivudine—hepatitis B	0.00177	0.00429	CcSEcCtD
Pazopanib—Hypoaesthesia—Telbivudine—hepatitis B	0.00173	0.0042	CcSEcCtD
Pazopanib—KDR—blood—hepatitis B	0.00173	0.00794	CbGeAlD
Pazopanib—MAP2K5—blood—hepatitis B	0.00173	0.00794	CbGeAlD
Pazopanib—FGFR2—liver—hepatitis B	0.00173	0.00792	CbGeAlD
Pazopanib—Connective tissue disorder—Telbivudine—hepatitis B	0.00171	0.00415	CcSEcCtD
Pazopanib—CSF1R—blood—hepatitis B	0.00169	0.00775	CbGeAlD
Pazopanib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00166	0.00404	CcSEcCtD
Pazopanib—Leukopenia—Entecavir—hepatitis B	0.00165	0.00401	CcSEcCtD
Pazopanib—CYP3A4—blood plasma—hepatitis B	0.0016	0.00734	CbGeAlD
Pazopanib—FLT1—liver—hepatitis B	0.0016	0.00734	CbGeAlD
Pazopanib—CYP2D6—blood plasma—hepatitis B	0.00158	0.00723	CbGeAlD
Pazopanib—Cough—Adefovir Dipivoxil—hepatitis B	0.00157	0.00381	CcSEcCtD
Pazopanib—Mediastinal disorder—Telbivudine—hepatitis B	0.00157	0.00381	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00156	0.00378	CcSEcCtD
Pazopanib—KIT—blood—hepatitis B	0.00153	0.00703	CbGeAlD
Pazopanib—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00153	0.00372	CcSEcCtD
Pazopanib—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00153	0.00372	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00152	0.00369	CcSEcCtD
Pazopanib—SLCO1B1—blood—hepatitis B	0.00152	0.00698	CbGeAlD
Pazopanib—Malnutrition—Telbivudine—hepatitis B	0.00152	0.00368	CcSEcCtD
Pazopanib—STK10—liver—hepatitis B	0.00152	0.00695	CbGeAlD
Pazopanib—TAOK3—liver—hepatitis B	0.00151	0.00692	CbGeAlD
Pazopanib—PDGFRA—liver—hepatitis B	0.0015	0.00688	CbGeAlD
Pazopanib—PDGFRB—blood—hepatitis B	0.0015	0.00687	CbGeAlD
Pazopanib—Infection—Entecavir—hepatitis B	0.0015	0.00363	CcSEcCtD
Pazopanib—Dysgeusia—Telbivudine—hepatitis B	0.00149	0.0036	CcSEcCtD
Pazopanib—Nervous system disorder—Entecavir—hepatitis B	0.00148	0.00358	CcSEcCtD
Pazopanib—Skin disorder—Entecavir—hepatitis B	0.00146	0.00355	CcSEcCtD
Pazopanib—Muscle spasms—Telbivudine—hepatitis B	0.00146	0.00354	CcSEcCtD
Pazopanib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00144	0.0035	CcSEcCtD
Pazopanib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00144	0.00349	CcSEcCtD
Pazopanib—UGT1A1—liver—hepatitis B	0.00143	0.00656	CbGeAlD
Pazopanib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00143	0.00346	CcSEcCtD
Pazopanib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0014	0.0034	CcSEcCtD
Pazopanib—Insomnia—Entecavir—hepatitis B	0.00136	0.0033	CcSEcCtD
Pazopanib—KDR—liver—hepatitis B	0.00135	0.00621	CbGeAlD
Pazopanib—MAP2K5—liver—hepatitis B	0.00135	0.00621	CbGeAlD
Pazopanib—Somnolence—Entecavir—hepatitis B	0.00134	0.00325	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00134	0.00325	CcSEcCtD
Pazopanib—Dyspepsia—Entecavir—hepatitis B	0.00133	0.00322	CcSEcCtD
Pazopanib—Cough—Telbivudine—hepatitis B	0.00132	0.00321	CcSEcCtD
Pazopanib—CSF1R—liver—hepatitis B	0.00132	0.00606	CbGeAlD
Pazopanib—Dehydration—Lamivudine—hepatitis B	0.00132	0.0032	CcSEcCtD
Pazopanib—Liver function test abnormal—Lamivudine—hepatitis B	0.00131	0.00318	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Entecavir—hepatitis B	0.0013	0.00315	CcSEcCtD
Pazopanib—Fatigue—Entecavir—hepatitis B	0.0013	0.00315	CcSEcCtD
Pazopanib—Abdominal pain upper—Lamivudine—hepatitis B	0.0013	0.00314	CcSEcCtD
Pazopanib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00129	0.00314	CcSEcCtD
Pazopanib—Myalgia—Telbivudine—hepatitis B	0.00129	0.00313	CcSEcCtD
Pazopanib—Chest pain—Telbivudine—hepatitis B	0.00129	0.00313	CcSEcCtD
Pazopanib—Arthralgia—Telbivudine—hepatitis B	0.00129	0.00313	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00128	0.00311	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00128	0.0031	CcSEcCtD
Pazopanib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00128	0.0031	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00127	0.00308	CcSEcCtD
Pazopanib—Nasopharyngitis—Lamivudine—hepatitis B	0.00127	0.00308	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00125	0.00303	CcSEcCtD
Pazopanib—Abdominal distension—Lamivudine—hepatitis B	0.00123	0.00299	CcSEcCtD
Pazopanib—Gastrointestinal pain—Entecavir—hepatitis B	0.00123	0.00299	CcSEcCtD
Pazopanib—Nervous system disorder—Telbivudine—hepatitis B	0.00121	0.00294	CcSEcCtD
Pazopanib—Thrombocytopenia—Telbivudine—hepatitis B	0.00121	0.00294	CcSEcCtD
Pazopanib—Pancreatitis—Lamivudine—hepatitis B	0.0012	0.00292	CcSEcCtD
Pazopanib—Skin disorder—Telbivudine—hepatitis B	0.0012	0.00291	CcSEcCtD
Pazopanib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0012	0.00291	CcSEcCtD
Pazopanib—KIT—liver—hepatitis B	0.0012	0.0055	CbGeAlD
Pazopanib—Abdominal pain—Entecavir—hepatitis B	0.00119	0.00289	CcSEcCtD
Pazopanib—SLCO1B1—liver—hepatitis B	0.00119	0.00546	CbGeAlD
Pazopanib—PDGFRB—liver—hepatitis B	0.00117	0.00537	CbGeAlD
Pazopanib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00116	0.00282	CcSEcCtD
Pazopanib—Neutropenia—Lamivudine—hepatitis B	0.00115	0.00278	CcSEcCtD
Pazopanib—ABCB1—blood plasma—hepatitis B	0.00113	0.0052	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00113	0.00273	CcSEcCtD
Pazopanib—Insomnia—Telbivudine—hepatitis B	0.00112	0.00271	CcSEcCtD
Pazopanib—Paraesthesia—Telbivudine—hepatitis B	0.00111	0.00269	CcSEcCtD
Pazopanib—Dyspepsia—Telbivudine—hepatitis B	0.00109	0.00264	CcSEcCtD
Pazopanib—Asthenia—Entecavir—hepatitis B	0.00108	0.00262	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00107	0.00259	CcSEcCtD
Pazopanib—Fatigue—Telbivudine—hepatitis B	0.00107	0.00259	CcSEcCtD
Pazopanib—Jaundice—Lamivudine—hepatitis B	0.00107	0.00258	CcSEcCtD
Pazopanib—Stomatitis—Lamivudine—hepatitis B	0.00107	0.00258	CcSEcCtD
Pazopanib—Pain—Telbivudine—hepatitis B	0.00106	0.00257	CcSEcCtD
Pazopanib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00105	0.00256	CcSEcCtD
Pazopanib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00104	0.00252	CcSEcCtD
Pazopanib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00103	0.00251	CcSEcCtD
Pazopanib—Epistaxis—Lamivudine—hepatitis B	0.00103	0.0025	CcSEcCtD
Pazopanib—Diarrhoea—Entecavir—hepatitis B	0.00103	0.0025	CcSEcCtD
Pazopanib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00101	0.00245	CcSEcCtD
Pazopanib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00101	0.00244	CcSEcCtD
Pazopanib—Dizziness—Entecavir—hepatitis B	0.000996	0.00242	CcSEcCtD
Pazopanib—Abdominal pain—Telbivudine—hepatitis B	0.000978	0.00237	CcSEcCtD
Pazopanib—Hypoaesthesia—Lamivudine—hepatitis B	0.000977	0.00237	CcSEcCtD
Pazopanib—Connective tissue disorder—Lamivudine—hepatitis B	0.000965	0.00234	CcSEcCtD
Pazopanib—Vomiting—Entecavir—hepatitis B	0.000958	0.00232	CcSEcCtD
Pazopanib—Rash—Entecavir—hepatitis B	0.00095	0.0023	CcSEcCtD
Pazopanib—Dermatitis—Entecavir—hepatitis B	0.000949	0.0023	CcSEcCtD
Pazopanib—Headache—Entecavir—hepatitis B	0.000944	0.00229	CcSEcCtD
Pazopanib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000935	0.00227	CcSEcCtD
Pazopanib—Rash—Adefovir Dipivoxil—hepatitis B	0.000927	0.00225	CcSEcCtD
Pazopanib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000926	0.00225	CcSEcCtD
Pazopanib—Headache—Adefovir Dipivoxil—hepatitis B	0.000921	0.00223	CcSEcCtD
Pazopanib—Nausea—Entecavir—hepatitis B	0.000895	0.00217	CcSEcCtD
Pazopanib—Asthenia—Telbivudine—hepatitis B	0.000888	0.00215	CcSEcCtD
Pazopanib—Mediastinal disorder—Lamivudine—hepatitis B	0.000885	0.00215	CcSEcCtD
Pazopanib—Chills—Lamivudine—hepatitis B	0.000881	0.00214	CcSEcCtD
Pazopanib—Pruritus—Telbivudine—hepatitis B	0.000876	0.00212	CcSEcCtD
Pazopanib—Nausea—Adefovir Dipivoxil—hepatitis B	0.000873	0.00212	CcSEcCtD
Pazopanib—Alopecia—Lamivudine—hepatitis B	0.000868	0.0021	CcSEcCtD
Pazopanib—CYP2C8—blood—hepatitis B	0.000866	0.00397	CbGeAlD
Pazopanib—Erythema—Lamivudine—hepatitis B	0.000855	0.00207	CcSEcCtD
Pazopanib—Malnutrition—Lamivudine—hepatitis B	0.000855	0.00207	CcSEcCtD
Pazopanib—Diarrhoea—Telbivudine—hepatitis B	0.000847	0.00205	CcSEcCtD
Pazopanib—Flatulence—Lamivudine—hepatitis B	0.000842	0.00204	CcSEcCtD
Pazopanib—ABCG2—blood—hepatitis B	0.000842	0.00386	CbGeAlD
Pazopanib—Dysgeusia—Lamivudine—hepatitis B	0.000837	0.00203	CcSEcCtD
Pazopanib—Muscle spasms—Lamivudine—hepatitis B	0.000822	0.00199	CcSEcCtD
Pazopanib—Dizziness—Telbivudine—hepatitis B	0.000818	0.00198	CcSEcCtD
Pazopanib—CYP1A2—blood—hepatitis B	0.00081	0.00372	CbGeAlD
Pazopanib—Anaemia—Lamivudine—hepatitis B	0.00079	0.00192	CcSEcCtD
Pazopanib—Vomiting—Telbivudine—hepatitis B	0.000787	0.00191	CcSEcCtD
Pazopanib—Rash—Telbivudine—hepatitis B	0.00078	0.00189	CcSEcCtD
Pazopanib—Dermatitis—Telbivudine—hepatitis B	0.00078	0.00189	CcSEcCtD
Pazopanib—Headache—Telbivudine—hepatitis B	0.000775	0.00188	CcSEcCtD
Pazopanib—Syncope—Lamivudine—hepatitis B	0.000766	0.00186	CcSEcCtD
Pazopanib—Leukopenia—Lamivudine—hepatitis B	0.000765	0.00185	CcSEcCtD
Pazopanib—Loss of consciousness—Lamivudine—hepatitis B	0.000751	0.00182	CcSEcCtD
Pazopanib—Cough—Lamivudine—hepatitis B	0.000746	0.00181	CcSEcCtD
Pazopanib—Nausea—Telbivudine—hepatitis B	0.000735	0.00178	CcSEcCtD
Pazopanib—Arthralgia—Lamivudine—hepatitis B	0.000728	0.00176	CcSEcCtD
Pazopanib—Chest pain—Lamivudine—hepatitis B	0.000728	0.00176	CcSEcCtD
Pazopanib—Myalgia—Lamivudine—hepatitis B	0.000728	0.00176	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000723	0.00175	CcSEcCtD
Pazopanib—Dry mouth—Lamivudine—hepatitis B	0.000712	0.00173	CcSEcCtD
Pazopanib—Oedema—Lamivudine—hepatitis B	0.000698	0.00169	CcSEcCtD
Pazopanib—Infection—Lamivudine—hepatitis B	0.000693	0.00168	CcSEcCtD
Pazopanib—Shock—Lamivudine—hepatitis B	0.000686	0.00166	CcSEcCtD
Pazopanib—Nervous system disorder—Lamivudine—hepatitis B	0.000684	0.00166	CcSEcCtD
Pazopanib—Thrombocytopenia—Lamivudine—hepatitis B	0.000683	0.00166	CcSEcCtD
Pazopanib—Skin disorder—Lamivudine—hepatitis B	0.000678	0.00164	CcSEcCtD
Pazopanib—CYP2C8—liver—hepatitis B	0.000677	0.00311	CbGeAlD
Pazopanib—Hyperhidrosis—Lamivudine—hepatitis B	0.000674	0.00163	CcSEcCtD
Pazopanib—Anorexia—Lamivudine—hepatitis B	0.000665	0.00161	CcSEcCtD
Pazopanib—ABCG2—liver—hepatitis B	0.000658	0.00302	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000636	0.00154	CcSEcCtD
Pazopanib—CYP1A2—liver—hepatitis B	0.000634	0.00291	CbGeAlD
Pazopanib—Insomnia—Lamivudine—hepatitis B	0.000631	0.00153	CcSEcCtD
Pazopanib—Paraesthesia—Lamivudine—hepatitis B	0.000626	0.00152	CcSEcCtD
Pazopanib—Dyspnoea—Lamivudine—hepatitis B	0.000622	0.00151	CcSEcCtD
Pazopanib—Somnolence—Lamivudine—hepatitis B	0.00062	0.0015	CcSEcCtD
Pazopanib—Dyspepsia—Lamivudine—hepatitis B	0.000614	0.00149	CcSEcCtD
Pazopanib—Decreased appetite—Lamivudine—hepatitis B	0.000606	0.00147	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000602	0.00146	CcSEcCtD
Pazopanib—Fatigue—Lamivudine—hepatitis B	0.000601	0.00146	CcSEcCtD
Pazopanib—Pain—Lamivudine—hepatitis B	0.000597	0.00145	CcSEcCtD
Pazopanib—CYP3A4—blood—hepatitis B	0.000587	0.00269	CbGeAlD
Pazopanib—CYP2D6—blood—hepatitis B	0.000577	0.00265	CbGeAlD
Pazopanib—Gastrointestinal pain—Lamivudine—hepatitis B	0.00057	0.00138	CcSEcCtD
Pazopanib—Abdominal pain—Lamivudine—hepatitis B	0.000551	0.00134	CcSEcCtD
Pazopanib—Asthenia—Lamivudine—hepatitis B	0.0005	0.00121	CcSEcCtD
Pazopanib—Pruritus—Lamivudine—hepatitis B	0.000494	0.0012	CcSEcCtD
Pazopanib—Diarrhoea—Lamivudine—hepatitis B	0.000477	0.00116	CcSEcCtD
Pazopanib—Dizziness—Lamivudine—hepatitis B	0.000461	0.00112	CcSEcCtD
Pazopanib—CYP3A4—liver—hepatitis B	0.000459	0.0021	CbGeAlD
Pazopanib—CYP2D6—liver—hepatitis B	0.000451	0.00207	CbGeAlD
Pazopanib—Vomiting—Lamivudine—hepatitis B	0.000444	0.00108	CcSEcCtD
Pazopanib—Rash—Lamivudine—hepatitis B	0.00044	0.00107	CcSEcCtD
Pazopanib—Dermatitis—Lamivudine—hepatitis B	0.000439	0.00107	CcSEcCtD
Pazopanib—Headache—Lamivudine—hepatitis B	0.000437	0.00106	CcSEcCtD
Pazopanib—ABCB1—blood—hepatitis B	0.000415	0.0019	CbGeAlD
Pazopanib—Nausea—Lamivudine—hepatitis B	0.000414	0.001	CcSEcCtD
Pazopanib—ABCB1—liver—hepatitis B	0.000325	0.00149	CbGeAlD
Pazopanib—FGFR1—Immune System—CD4—hepatitis B	2.15e-05	6.53e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD4—hepatitis B	2.15e-05	6.51e-05	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—IL6—hepatitis B	2.15e-05	6.5e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—hepatitis B	2.13e-05	6.47e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD4—hepatitis B	2.13e-05	6.47e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL2—hepatitis B	2.13e-05	6.45e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TGFB1—hepatitis B	2.13e-05	6.44e-05	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—IL6—hepatitis B	2.11e-05	6.39e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CD4—hepatitis B	2.09e-05	6.35e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL2—hepatitis B	2.09e-05	6.33e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL10—hepatitis B	2.06e-05	6.25e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IL6—hepatitis B	2.06e-05	6.25e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CTNNB1—hepatitis B	2.05e-05	6.22e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TGFB1—hepatitis B	2.04e-05	6.19e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—F2—hepatitis B	2.04e-05	6.19e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—CTNNB1—hepatitis B	2.02e-05	6.11e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CDKN1A—hepatitis B	2e-05	6.08e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—F2—hepatitis B	2e-05	6.08e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—hepatitis B	2e-05	6.08e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—PTEN—hepatitis B	2e-05	6.06e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—IL6—hepatitis B	2e-05	6.06e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—hepatitis B	2e-05	6.06e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2e-05	6.06e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—IL6—hepatitis B	1.99e-05	6.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCR5—hepatitis B	1.99e-05	6.04e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—IL6—hepatitis B	1.99e-05	6.04e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NFKB1—hepatitis B	1.99e-05	6.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—hepatitis B	1.99e-05	6.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—hepatitis B	1.98e-05	6.01e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—hepatitis B	1.98e-05	6.01e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—hepatitis B	1.98e-05	5.99e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP2A6—hepatitis B	1.97e-05	5.98e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—CDKN1A—hepatitis B	1.97e-05	5.97e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—PTEN—hepatitis B	1.96e-05	5.96e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—hepatitis B	1.96e-05	5.95e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—NFKB1—hepatitis B	1.95e-05	5.93e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCR5—hepatitis B	1.95e-05	5.91e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS2—hepatitis B	1.94e-05	5.87e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—hepatitis B	1.94e-05	5.87e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CTNNB1—hepatitis B	1.93e-05	5.85e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CTNNB1—hepatitis B	1.91e-05	5.8e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CTNNB1—hepatitis B	1.91e-05	5.78e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—F2—hepatitis B	1.9e-05	5.77e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—F2—hepatitis B	1.9e-05	5.75e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CTNNB1—hepatitis B	1.89e-05	5.74e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—hepatitis B	1.89e-05	5.74e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CDKN1A—hepatitis B	1.88e-05	5.71e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—PTEN—hepatitis B	1.88e-05	5.7e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—NFKB1—hepatitis B	1.87e-05	5.67e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CDKN1A—hepatitis B	1.87e-05	5.67e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PTEN—hepatitis B	1.86e-05	5.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CDKN1A—hepatitis B	1.86e-05	5.65e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CTNNB1—hepatitis B	1.86e-05	5.64e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PTEN—hepatitis B	1.86e-05	5.64e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NFKB1—hepatitis B	1.86e-05	5.63e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CDKN1A—hepatitis B	1.85e-05	5.61e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NFKB1—hepatitis B	1.85e-05	5.61e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—TGFB1—hepatitis B	1.85e-05	5.61e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PTEN—hepatitis B	1.85e-05	5.6e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.84e-05	5.58e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.82e-05	5.53e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CDKN1A—hepatitis B	1.82e-05	5.51e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL6—hepatitis B	1.82e-05	5.51e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—PTEN—hepatitis B	1.81e-05	5.5e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—hepatitis B	1.8e-05	5.45e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—hepatitis B	1.79e-05	5.42e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—hepatitis B	1.79e-05	5.42e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT2—hepatitis B	1.78e-05	5.41e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—hepatitis B	1.78e-05	5.4e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CTNNB1—hepatitis B	1.77e-05	5.35e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CTNNB1—hepatitis B	1.76e-05	5.34e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—hepatitis B	1.76e-05	5.33e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—hepatitis B	1.75e-05	5.31e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT2—hepatitis B	1.75e-05	5.3e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—hepatitis B	1.74e-05	5.29e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—hepatitis B	1.74e-05	5.28e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CDKN1A—hepatitis B	1.73e-05	5.23e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CTNNB1—hepatitis B	1.72e-05	5.23e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PTEN—hepatitis B	1.72e-05	5.22e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CDKN1A—hepatitis B	1.72e-05	5.22e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CTNNB1—hepatitis B	1.72e-05	5.21e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP2A6—hepatitis B	1.72e-05	5.21e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PTEN—hepatitis B	1.72e-05	5.21e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—F2—hepatitis B	1.71e-05	5.18e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CDKN1A—hepatitis B	1.68e-05	5.11e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CTNNB1—hepatitis B	1.68e-05	5.1e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PTEN—hepatitis B	1.68e-05	5.1e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CTNNB1—hepatitis B	1.68e-05	5.1e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—hepatitis B	1.68e-05	5.09e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CDKN1A—hepatitis B	1.68e-05	5.09e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—hepatitis B	1.68e-05	5.09e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PTEN—hepatitis B	1.68e-05	5.08e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—F2—hepatitis B	1.67e-05	5.07e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NFKB1—hepatitis B	1.67e-05	5.07e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NFKB1—hepatitis B	1.67e-05	5.06e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—hepatitis B	1.66e-05	5.04e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CDKN1A—hepatitis B	1.64e-05	4.98e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CDKN1A—hepatitis B	1.64e-05	4.98e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—PTEN—hepatitis B	1.64e-05	4.97e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PTEN—hepatitis B	1.64e-05	4.97e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—NFKB1—hepatitis B	1.63e-05	4.95e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NFKB1—hepatitis B	1.63e-05	4.94e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.62e-05	4.91e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—hepatitis B	1.61e-05	4.88e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CTNNB1—hepatitis B	1.6e-05	4.86e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR5—hepatitis B	1.6e-05	4.85e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CTNNB1—hepatitis B	1.59e-05	4.81e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CDKN1A—hepatitis B	1.57e-05	4.75e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PTEN—hepatitis B	1.56e-05	4.74e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TGFB1—hepatitis B	1.56e-05	4.73e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—hepatitis B	1.56e-05	4.72e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NFKB1—hepatitis B	1.56e-05	4.72e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT2—hepatitis B	1.55e-05	4.71e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—hepatitis B	1.55e-05	4.71e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CDKN1A—hepatitis B	1.55e-05	4.7e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTEN—hepatitis B	1.55e-05	4.69e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT1—hepatitis B	1.54e-05	4.67e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GGT1—hepatitis B	1.54e-05	4.67e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—hepatitis B	1.54e-05	4.66e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFB1—hepatitis B	1.53e-05	4.64e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.52e-05	4.62e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—hepatitis B	1.51e-05	4.58e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFB1—hepatitis B	1.5e-05	4.56e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT2—hepatitis B	1.46e-05	4.44e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—hepatitis B	1.44e-05	4.37e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—hepatitis B	1.43e-05	4.35e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—hepatitis B	1.43e-05	4.33e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFB1—hepatitis B	1.43e-05	4.33e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—hepatitis B	1.43e-05	4.32e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFB1—hepatitis B	1.42e-05	4.32e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.4e-05	4.25e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—hepatitis B	1.39e-05	4.23e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFB1—hepatitis B	1.39e-05	4.22e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CTNNB1—hepatitis B	1.38e-05	4.18e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—hepatitis B	1.37e-05	4.17e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2A6—hepatitis B	1.37e-05	4.16e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—F2—hepatitis B	1.37e-05	4.16e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFB1—hepatitis B	1.36e-05	4.12e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—hepatitis B	1.35e-05	4.09e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CDKN1A—hepatitis B	1.35e-05	4.09e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—PTEN—hepatitis B	1.34e-05	4.08e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GGT1—hepatitis B	1.34e-05	4.07e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT1—hepatitis B	1.34e-05	4.07e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—NFKB1—hepatitis B	1.34e-05	4.06e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CTNNB1—hepatitis B	1.33e-05	4.02e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—hepatitis B	1.32e-05	4e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CTNNB1—hepatitis B	1.3e-05	3.95e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CDKN1A—hepatitis B	1.3e-05	3.93e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFB1—hepatitis B	1.3e-05	3.93e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PTEN—hepatitis B	1.29e-05	3.92e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NFKB1—hepatitis B	1.29e-05	3.9e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—hepatitis B	1.28e-05	3.89e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFB1—hepatitis B	1.28e-05	3.89e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—hepatitis B	1.28e-05	3.88e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.28e-05	3.88e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—hepatitis B	1.28e-05	3.87e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CTNNB1—hepatitis B	1.27e-05	3.86e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CDKN1A—hepatitis B	1.27e-05	3.86e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PTEN—hepatitis B	1.27e-05	3.85e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT1—hepatitis B	1.26e-05	3.83e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GGT1—hepatitis B	1.26e-05	3.83e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NFKB1—hepatitis B	1.26e-05	3.83e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—hepatitis B	1.25e-05	3.79e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CDKN1A—hepatitis B	1.24e-05	3.77e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTEN—hepatitis B	1.24e-05	3.76e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT2—hepatitis B	1.24e-05	3.76e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CTNNB1—hepatitis B	1.24e-05	3.75e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CTNNB1—hepatitis B	1.23e-05	3.74e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—hepatitis B	1.23e-05	3.72e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CDKN1A—hepatitis B	1.21e-05	3.66e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PTEN—hepatitis B	1.21e-05	3.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CDKN1A—hepatitis B	1.2e-05	3.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PTEN—hepatitis B	1.2e-05	3.65e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NFKB1—hepatitis B	1.2e-05	3.64e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NFKB1—hepatitis B	1.2e-05	3.63e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTEN—hepatitis B	1.19e-05	3.6e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—hepatitis B	1.17e-05	3.56e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—hepatitis B	1.16e-05	3.53e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—hepatitis B	1.16e-05	3.52e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—hepatitis B	1.15e-05	3.5e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—hepatitis B	1.15e-05	3.49e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—hepatitis B	1.15e-05	3.48e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—hepatitis B	1.13e-05	3.44e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—hepatitis B	1.13e-05	3.42e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—hepatitis B	1.12e-05	3.39e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CTNNB1—hepatitis B	1.11e-05	3.37e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CTNNB1—hepatitis B	1.09e-05	3.3e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTEN—hepatitis B	1.09e-05	3.3e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN1A—hepatitis B	1.09e-05	3.29e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PTEN—hepatitis B	1.08e-05	3.28e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NFKB1—hepatitis B	1.08e-05	3.27e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—hepatitis B	1.08e-05	3.26e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—hepatitis B	1.07e-05	3.25e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—hepatitis B	1.07e-05	3.25e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGT1—hepatitis B	1.07e-05	3.25e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT1—hepatitis B	1.07e-05	3.25e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—hepatitis B	1.07e-05	3.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN1A—hepatitis B	1.06e-05	3.22e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PTEN—hepatitis B	1.06e-05	3.22e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.06e-05	3.21e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NFKB1—hepatitis B	1.06e-05	3.2e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—hepatitis B	1.05e-05	3.19e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—hepatitis B	1.05e-05	3.18e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—hepatitis B	1.05e-05	3.17e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—hepatitis B	1.03e-05	3.12e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—hepatitis B	1.02e-05	3.11e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—hepatitis B	1.02e-05	3.1e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTEN—hepatitis B	1.01e-05	3.05e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—hepatitis B	9.99e-06	3.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—hepatitis B	9.97e-06	3.02e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—hepatitis B	9.76e-06	2.96e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.76e-06	2.96e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—hepatitis B	9.66e-06	2.93e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT2—hepatitis B	9.58e-06	2.9e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—hepatitis B	9.24e-06	2.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—hepatitis B	8.98e-06	2.72e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CTNNB1—hepatitis B	8.92e-06	2.7e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—hepatitis B	8.83e-06	2.68e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—hepatitis B	8.79e-06	2.67e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN1A—hepatitis B	8.71e-06	2.64e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTEN—hepatitis B	8.69e-06	2.64e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—hepatitis B	8.67e-06	2.63e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NFKB1—hepatitis B	8.65e-06	2.62e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—hepatitis B	8.4e-06	2.55e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT1—hepatitis B	8.27e-06	2.51e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT1—hepatitis B	8.27e-06	2.51e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—hepatitis B	8.23e-06	2.49e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—hepatitis B	8.2e-06	2.49e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—hepatitis B	8.19e-06	2.48e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—hepatitis B	8.08e-06	2.45e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—hepatitis B	7.93e-06	2.41e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—hepatitis B	7.75e-06	2.35e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—hepatitis B	7.53e-06	2.28e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—hepatitis B	7.51e-06	2.28e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—hepatitis B	7.39e-06	2.24e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—hepatitis B	7.24e-06	2.19e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—hepatitis B	7.21e-06	2.18e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—hepatitis B	7.14e-06	2.16e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—hepatitis B	6.77e-06	2.05e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—hepatitis B	6.72e-06	2.04e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—hepatitis B	6.62e-06	2.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTEN—hepatitis B	6.25e-06	1.89e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—hepatitis B	5.93e-06	1.8e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—hepatitis B	5.7e-06	1.73e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTEN—hepatitis B	5.44e-06	1.65e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—hepatitis B	5.43e-06	1.65e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTEN—hepatitis B	5.13e-06	1.56e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—hepatitis B	4.4e-06	1.33e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTEN—hepatitis B	4.35e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTEN—hepatitis B	3.35e-06	1.02e-05	CbGpPWpGaD
